Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial.

MLA

Jiang, Ping, et al. “Hypo-Fractionated SBRT for Localized Prostate Cancer: A German Bi-Center Single Treatment Group Feasibility Trial.” Radiation Oncology, vol. 12, no. 1, Aug. 2017, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s13014-017-0872-2.

APA

Jiang, P., Krockenberger, K., Vonthein, R., Tereszczuk, J., Schreiber, A., Liebau, S., Huttenlocher, S., Imhoff, D., Balermpas, P., Keller, C., Dellas, K., Baumann, R., Rödel, C., Hildebrandt, G., Jünemann, K.-P., Merseburger, A., Katz, A., Ziegler, A., Blanck, O., & Dunst, J. (2017). Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial. Radiation Oncology, 12(1), 1–7. https://doi.org/10.1186/s13014-017-0872-2

Chicago

Jiang, Ping, Katja Krockenberger, Reinhard Vonthein, Jane Tereszczuk, Arne Schreiber, Sebastian Liebau, Stefan Huttenlocher, et al. 2017. “Hypo-Fractionated SBRT for Localized Prostate Cancer: A German Bi-Center Single Treatment Group Feasibility Trial.” Radiation Oncology 12 (1): 1–7. doi:10.1186/s13014-017-0872-2.